Delivery Order SPE2DB22D3301-SPE2DB25FX9AW
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has a ceiling value of $1,707.40 and runs through January 11, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication for the treatment of diabetes. The contract has a ceiling value of $1,535.66 and a period of performance ending on April 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a firm fixed price of $1,459.92 and a period of performance ending on March 17, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.77 firm-fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a ceiling value of $1,285.20 and runs through January 17, 2023. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,801.26 and is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract runs through June 25, 2024 and is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.64, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has a period of performance through March 3, 2025 and is structured as a firm fixed-price arrangement. No set-aside designation was used for this award. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The firm-fixed-price delivery order has a ceiling value of $1,176.22 and an ultimate completion date of March 11, 2025. The contract is not designated under a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract has a ceiling value of $17,365.18 and a period of performance through October 18, 2023. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medical devices. The award has a ceiling value of $1,187.60 and is a Firm Fixed Price contract with an ultimate completion date of October 29, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...